| Application no. and date | 02758562.9 (espacenet) (Federated) (European Patent Register), 20020903 | | Patent/reg. no. and date | DK/EP 1423105, 20081203 | | Publication date | 20040602 | | Priority no. and date | GB 0121285, 20010903 | | EP pub. no. and date |
EP 1423105 20040602 | | Effective date | | | Applicant/owner | Cancer Research Technology Limited, Sardinia House
Sardinia Street
London WC2A 3NL, GB | | Applicant ref. no. | 132971 | | Inventor | SIIM, Bronwyn, Gae, 89 King Edward Street
Mt Eden, Auckland, NZ,
WILSON, William, Robert, 199 Smith Road
RD2, Waiuku, NZ | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/19 (2006.01) , A61K 31/475 (2006.01) , A61K 31/505 (2006.01) , A61K 31/65 (2006.01) , A61K 31/66 (2006.01) , A61K 31/70 (2006.01) , A61K 33/24 (2006.01) , A61P 35/00 (2006.01) | | Title | Sammensætninger af DMXAA og andre anticancermidler | | Int. application no. | GB2002004025 | | Int. publication no. | WO2003020259 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
